These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions. Favaloro EJ Semin Thromb Hemost; 2014 Jul; 40(5):551-70. PubMed ID: 24978322 [TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. Miller JL; Kupinski JM; Castella A; Ruggeri ZM J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113 [TBL] [Abstract][Full Text] [Related]
5. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers. Weiss HJ; Sussman II Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353 [TBL] [Abstract][Full Text] [Related]
6. Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor. Ware J; Dent JA; Azuma H; Sugimoto M; Kyrle PA; Yoshioka A; Ruggeri ZM Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2946-50. PubMed ID: 2011604 [TBL] [Abstract][Full Text] [Related]
7. Spontaneous platelet aggregation in type IIB Tampa von Willebrand disease is inhibited by the 52/48-kDa fragment of normal von Willebrand factor, which contains the GPIb binding domain. Saba HI; Fujimura Y; Saba SR; Bruce AC; Morelli GA; Ruggeri ZM; Zimmerman TS Am J Hematol; 1989 Mar; 30(3):150-3. PubMed ID: 2783833 [TBL] [Abstract][Full Text] [Related]
8. Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib. Rabinowitz I; Randi AM; Shindler KS; Tuley EA; Rustagi PK; Sadler JE J Biol Chem; 1993 Sep; 268(27):20497-501. PubMed ID: 8376405 [TBL] [Abstract][Full Text] [Related]
9. New variant of type II von Willebrand's disease with structural abnormality of plasma von Willebrand factor in a patient with very mild bleeding history. Baillod P; Gaucher C; Affolter B; Mazurier C; Pflugshaupt R Am J Hematol; 1995 May; 49(1):21-8. PubMed ID: 7741134 [TBL] [Abstract][Full Text] [Related]
10. Erik von Willebrand. Berntorp E Thromb Res; 2007; 120 Suppl 1():S3-4. PubMed ID: 17512040 [TBL] [Abstract][Full Text] [Related]
11. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets. Cooney KA; Lyons SE; Ginsburg D Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393 [TBL] [Abstract][Full Text] [Related]
12. Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets. Kroner PA; Kluessendorf ML; Scott JP; Montgomery RR Blood; 1992 Apr; 79(8):2048-55. PubMed ID: 1373334 [TBL] [Abstract][Full Text] [Related]
13. Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity. Federici AB; Mannucci PM; Lombardi R; Lattuada A; Colibretti ML; Dent JA; Zimmerman TS Am J Hematol; 1989 Dec; 32(4):287-93. PubMed ID: 2510503 [TBL] [Abstract][Full Text] [Related]
14. Von Willebrand factor: molecular size and functional activity. Furlan M Ann Hematol; 1996 Jun; 72(6):341-8. PubMed ID: 8767102 [TBL] [Abstract][Full Text] [Related]
15. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease. Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338 [TBL] [Abstract][Full Text] [Related]
16. Type 2B von Willebrand disease and related disorders of patients with increased ristocetin-induced platelet aggregation: what they tell us about the role of von Willebrand factor in hemostasis. Weiss HJ J Thromb Haemost; 2004 Nov; 2(11):2055-6. PubMed ID: 15550048 [No Abstract] [Full Text] [Related]
17. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis. Casonato A; Sartorello F; Pontara E; Gallinaro L; Bertomoro A; Grazia Cattini M; Daidone V; Szukowska M; Pagnan A Thromb Haemost; 2007 Dec; 98(6):1182-7. PubMed ID: 18064311 [TBL] [Abstract][Full Text] [Related]
18. Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease. Ribba AS; Christophe O; Derlon A; Cherel G; Siguret V; Lavergne JM; Girma JP; Meyer D; Pietu G Blood; 1994 Feb; 83(3):833-41. PubMed ID: 8298143 [TBL] [Abstract][Full Text] [Related]
19. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor. Inbal A; Kornbrot N; Harrison P; Randi AM; Sadler JE Thromb Haemost; 1993 Dec; 70(6):1058-62. PubMed ID: 8165601 [TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor and von Willebrand disease. Ruggeri ZM; Zimmerman TS Blood; 1987 Oct; 70(4):895-904. PubMed ID: 3307951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]